Synlogic is conducting a phase 1 clinical research study to evaluate the potential new treatment option for hyperoxaluria (HOX), a condition that can cause kidney stones and kidney disease in some people following bariatric surgery.
A potential oral treatment to treat HOX after bariatric surgery
Enrolling participants 18–74 who have had bariatric surgery more than one year ago
Participant may or may not have had kidney stones
All participants will receive the study drug during the study
Study participants have the option to participate either at a study clinic or at a remote location such as their home with a home health professional